Holly Valdiviez

Holly Valdiviez serves as the Senior Vice President and Head of Sales at Acadia Pharmaceuticals Inc., where leadership encompasses three customer-facing teams focused on Neuroscience, Long-Term Care, and Health Systems. With a notable history of driving sales growth, Holly achieved eight consecutive quarters of TRx growth and a 107% revenue increase during tenure as VP Sales at Adamas Pharmaceuticals. At Amgen, Holly successfully led a 200-member sales organization in launching a first-in-class migraine prevention medicine, earning the "Drug Launch of the Year" award. Previous roles include Vice President at Sio Gene Therapies and Otsuka Pharmaceutical Companies, where Holly oversaw extensive sales organizations and significantly exceeded performance forecasts. Holly's career began at Bristol-Myers Squibb, where experience spanned multiple therapeutic areas. Holly holds a Bachelor of Arts in Business/Corporate Communication from Buena Vista University and completed Executive Education at Harvard University.